Ingredient | Species | General toxicology | Reproductive effects | References |
---|---|---|---|---|
Methylsulfonylmethane | Human | • Topically, there are no adverse reactions. | • Till date, no data. | |
• There are no studies on long-term use. |  | |||
Animal | • Orally, it has low toxicity. | • Do not induce structural or fetal anomalies. | ||
• Long-term use did not cause adverse events. |  | |||
Camphor | Human | • Topically, poisonings were reported in children and adults. | • Topically, the frequency of birth defects was less. | |
• Orally, it caused fatal symptoms in children. | • Orally, cross the human placenta, however, till date, there are no adverse fetal effects. | |||
Animal | • The oral LD50 = 1.3 g/kg in mice. | • Orally, there are no congenital abnormalities in rats and rabbit. | ||
Menthol | Human | • Topically, it is safe. | • Till date, no data. | |
Animal | • Topically, acute dermal toxicity was reported with LD50 = 5 g/kg in rabbit. | • There is no teratogenic effect in mice, rats, hamsters, or rabbits. | ||
• Orally, toxicity was reported at LD50 = 2.9 g/kg and 3.1 g/kg in rat and mice, respectively. |  | |||
Wintergreen Oil | Human | • In cosmetics, methyl salicylate is safe, however, might cause local necrosis. | • Till date, no data. | |
• There are some reports for tinnitus, diplopia, shortness of breath, and respiratory alkalosis. |  | |||
Animal | • Topically, sub-chronic exposure might lead to kidney damage in rats. | • It is associated with increased risk of abnormalities. | ||
Glucosamine Sulfate | Human | • Topically, it did not cause toxicity or adverse effects. | • There is no increase in risk of malformations. | |
Animal | • Topically, it is considered safe. | • Teratogenic effects were not reported in mice or rabbits exposed to glucosamine. | ||
Sodium Chondroitin Sulfate | Human | • Topically, there are no adverse events. | • Till date, no data | |
• It interferes with progression of osteoarthritis. |  | |||
Animal | • The oral LD50 for mice is greater than 10 g/kg. | • There is increased risk of cleft palate and tail abnormalities in mice. | ||
 | • Orally, there are no adverse effects in mice and rabbits. | |||
Eucalyptus Leaf Oil) | Human | • Topically, it is safe. | • Till date, no data. | |
• A report of fever and seizure-like motor activity -in slurred speech, ataxia, and muscle weakness were reported in children. |  | |||
• Orally, there are minor side effects. |  | |||
Animal | The oral LD50 = 2.5 g/kg in rats. | • There are no adverse outcomes in mice. | ||
Grape Seed Oil | Human | • Topically, it is safe. | • Till date, no data. | |
Animal | • There are no safety issues associated with acute and chronic safety studies rats | • The grape seed extract was non-mutagenic in mice. | ||
 | • Several reports showed that LD50 for dermal application is greater than 2 g/kg in rats. | |||
Vitamine E | Human | • Topically, it is safe. | • There are no risks of stillbirth, perinatal death, preterm birth, intrauterine growth restriction, or mean birth weight. | |
 | • High doses were associated with reduction in birth weight. | |||
Animal | • Topically, it is safe. | • Malformation was not greater than expected in offspring of rats and mice. | ||
Thymol | Human | • Topically, it is safe. | • It is not associated with increased risks of birth defects. | |
• It is toxic to mucous membranes and to kidneys, liver, and central nervous system. |  | |||
Animal | • Topically, it is safe. | • Might cause adverse reproductive effects. | ||
Sea Cucumber Extract | Human | • Topically, it is safe | • Till date, no data. | |
Animal | • Topically, it is safe. | • Till date, no data. | ||
Aloe Barbadensis Leaf Juice | Human | • Topically, it is safe, however, not recommended for children under age of 12 years. | • Orally, it is not recommended in pregnancy or lactation. | |
• Orally, there are adverse effects in rare cases. |  | |||
Animal | • Topically, it is safe. | • Teratogenic effects have been reported with high oral doses in rats. | ||
Peppermint Oil | Human | • Topically, it caused skin irritation with frequent use of oil. | • It induces menstruation and, thus, it is not recommended at high oral doses during pregnancy. | |
• Orally, enteric-coated capsules were not associated with adverse reactions. | • There is insufficient evidence to determine the safety of peppermint oil during lactation. | |||
Animal | • The oral LD50 was reported at 2490 mg/kg in mice and at 2426 mg/kg in rats. | • Orally, the LD50 was 2490 mg/kg in mice and 2426 mg/kg in rats. | ||
 | • The peppermint oil was used to induce menstruation and it is not recommended at high oral doses in pregnancy. | |||
Boswelli, and Magnesium chloride | Human | • Topically, boswelli is associated with dermatitis. | • Orally, there is lack of evidence on safe use of boswelli during pregnancy and lactation. | |
• Orally, boswelli is associated with gastrointestinal effects including, nausea, abdominal fullness, and epigastria. | • Similarly, magnesium chloride studies failed to demonstrate risks of birth defects to the fetus. | |||
• Orally, magnesium chloride is not recommended for patients with renal impairment. |  | |||
• Both magnesium and ilex are safe for topical use. |  | |||
Animal | • Topically, boswelli is safe in mice, rats and monkeys. | • There is lack of evidence on safe use during pregnancy and lactation. | ||
• Orally, boswelli was not associated with mortality in rat and mice. |  | |||
• In rat and monkey, there was no change in behavior, clinical, biochemical, or pathological data when boswelli was used orally. |  |